Cross-fund · 5 holders
TNXP
TONIX PHARMACEUTICALS HLDG C
CUSIP 890260839
5
Tracked holders
$35.6M
Aggregate value
2,498,681
Shares
5
Active funds
Funds holding TNXP
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $13.3M | — | +83,296 | +9.4% |
| Vanguard | Institutional | Q4 2025 | $10.5M | — | +116,648 | +20.9% |
| Citadel | Multi-Strategy | Q1 2026 | $7.0M | — | +472,012 | +1186.0% |
| Millennium | Multi-Strategy | Q1 2026 | $3.0M | — | +196,727 | +857.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.7M | — | −494,619 | −79.8% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.